No black box warning on record for Tecentriq Hybreza
As of the latest FDA labeling reviewed, Tecentriq Hybreza (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) does not carry a black box warning. Standard warnings and precautions still apply — see the full Tecentriq Hybreza medicine page for the complete safety profile.